ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

31,128Medicare Part D Prescriptions Filled, Including Refills

Rank: 21 out of 2087

$1.56M Total Retail Price of All Prescriptions

Rank: 34 out of 2087

918 Patients Receiving at Least One Drug in Part D
95% Patients 65 Years and Older
45% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Ohio
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

7% of this provider’s 918 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

9% of this provider’s 918 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

34 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Ohio
FUROSEMIDE 2,107 2,073 254 1 7
LEVOTHYROXINE SODIUM 1,392 1,345 232 2 2
LISINOPRIL 935 899 177 3 1
OMEPRAZOLE 928 915 188 4 5
NAMENDA 882 882 103 5 30
WARFARIN SODIUM 871 871 78 6 12
ATORVASTATIN CALCIUM 697 685 126 7 6
AMLODIPINE BESYLATE 692 673 138 8 4
DONEPEZIL HCL 659 654* 116 9 26
ESCITALOPRAM OXALATE 606 601* 111 10 55
METOPROLOL TARTRATE 523 512 114 11 8
MIRTAZAPINE 520 515* 110 12 49
SIMVASTATIN 500 485 106 13 3
POTASSIUM CHLORIDE 476 471* 94 14 17
GABAPENTIN 455 437 86 15 14
BUSPIRONE HCL 452 447* 83 16 106
CLOPIDOGREL 370 365* 64 17 18
EXELON 342 342 56 18 99
CITALOPRAM HBR 336 331* 83 19 21
TRAMADOL HCL 326 321* 114 20 19
ALBUTEROL SULFATE 313 308* 98 21 120
PANTOPRAZOLE SODIUM 300 295* 66 22 32
HYDROCODONE-ACETAMINOPHEN 298 293* 76 S3 23 10
PREDNISONE 288 283* 79 24 37
METOPROLOL SUCCINATE 264 259* 52 25 20
DIVALPROEX SODIUM 260 255* 47 26 78
METFORMIN HCL 259 247 54 27 9
ALENDRONATE SODIUM 258 258 48 28 35
LANTUS 255 250* 43 29 59
HYDROCHLOROTHIAZIDE 251 246* 60 30 11
LOSARTAN POTASSIUM 249 244* 44 31 15
TAMSULOSIN HCL 237 232* 48 32 28
NYSTATIN 232 227* 103 33 149
CYMBALTA 216 199 36 34 51
ALLOPURINOL 213 208* 36 35 27
CARVEDILOL 209 204* 39 36 23
AZITHROMYCIN 205 200* 133 37 45
CIPROFLOXACIN HCL 204 199* 117 38 56
POLYETHYLENE GLYCOL 3350 187 182* 59 39 72
SERTRALINE HCL 185 173 40 40 22
KLOR-CON M20 185 180* 41 40 50
GLIMEPIRIDE 185 172 32 40 34
FAMOTIDINE* 179 166 26 43 75
LISINOPRIL-HYDROCHLOROTHIAZIDE 173 161 31 44 29
TRAZODONE HCL 163 158* 40 45 39
DIGOX 153 153 29 46 91
LEVOFLOXACIN 152 147* 93 47 90
DOXYCYCLINE HYCLATE 148 143* 83 48 113
LORAZEPAM 148 134 51 B 48 25
SPIRONOLACTONE 139 139 32 50 62
ROPINIROLE HCL 138 138 19 51 94
LIDODERM 136 131* 49 52 129
MELOXICAM 136 131* 56 52 44
SULFAMETHOXAZOLE-TRIMETHOPRIM 136 131* 78 52 95
ATENOLOL 135 130* 28 55 16
NITROGLYCERIN PATCH 134 134 20 56 219
CEPHALEXIN 133 128* 69 57 105
NOVOLOG 132 127* 37 58 107
PRAVASTATIN SODIUM 131 131 28 59 13
CARBIDOPA-LEVODOPA 129 129 21 60 121
SPIRIVA 128 123* 31 61 67
ISOSORBIDE MONONITRATE ER 125 125 20 62 46
LEVETIRACETAM 124 124 16 63 101
KLOR-CON M10 123 123 25 64 124
LATANOPROST 123 123 18 64 177
ADVAIR DISKUS 117 112* 30 66 63
FLUTICASONE PROPIONATE 116 111* 32 67 38
ENULOSE 114 114 18 68 178
QUETIAPINE FUMARATE 113 108* 30 A 69 61
LACTULOSE 109 109 28 70 138
NITROFURANTOIN MONO-MACRO 103 103 36 71 184
FENTANYL 103 103 26 S2 71 102
ZOLPIDEM TARTRATE 102 97* 27 73 31
DILTIAZEM 24HR CD 100 100 24 74 141
VOLTAREN 98 93* 54 75 176
DOXAZOSIN MESYLATE 96 96 16 76 82
NEXIUM 96 91* 14 76 33
LYRICA 95 90* 16 78 81
CLONAZEPAM 88 83* 23 B 79 64
FINASTERIDE 88 88 21 79 83
IPRATROPIUM-ALBUTEROL 86 86 17 81 111
BYSTOLIC 86 81* 14 81 119
CEFTRIAXONE* 85 85 55 83 229
DIOVAN 85 85 14 83 48
PAROXETINE HCL 83 78* 15 85 66
ALPRAZOLAM 83 83 20 B 85 24
MONTELUKAST SODIUM 82 82 19 87 53
DIGOXIN 81 81 19 88 175
HYDRALAZINE HCL 81 76* 16 88 69
NUEDEXTA 77 77 12 90 274
METRONIDAZOLE 72 72 25 91 240
CEFUROXIME 69 64* 43 92 159
AMOXICILLIN 68 68 39 93 109
PROMETHAZINE HCL 68 63* 49 R 93 145
TRIMETHOPRIM 68 <11 <11 93 314
GLIPIZIDE 67 67 12 96 57
LANTUS SOLOSTAR 66 61* 14 97 68
IPRATROPIUM BROMIDE 65 <11 <11 98 193
VENLAFAXINE HCL ER 65 60* 13 98 97
RISPERIDONE 61 61 20 A 100 73
RANITIDINE HCL 60 55* 11 101 60
FLUOCINONIDE 60 60 37 101 250
PRADAXA 59 <11 <11 103 195
CLONIDINE 58 58 13 104 270
NAMENDA XR 58 58 12 104 267
FENOFIBRATE* 57 <11 <11 106 71
CLONIDINE HCL 57 52* 28 106 58
CRESTOR 56 51* 14 108 36
NOVOLOG FLEXPEN 56 <11 <11 108 137
TIMOLOL MALEATE 54 54 11 110 386
XARELTO 53 <11 <11 111 180
CLOTRIMAZOLE-BETAMETHASONE 53 53 27 111 190
KLOR-CON 10 53 53 12 111 132
OLANZAPINE 52 <11 <11 A 114 117
VERAPAMIL ER 52 <11 <11 114 110
LIDOCAINE HCL* 51 51 41 116 309
NITROFURANTOIN* 51 51 18 116 217
OXYBUTYNIN CHLORIDE ER 51 <11 <11 116 77
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 16, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.